SES Reaches 351 Million TV Homes Worldwide

LUXEMBOURG -Wednesday, April 4th 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- The number of video households served by SES has continued to increase, reaching 351 million TV homes in 2017 according to SES’s annual market research, Satellite Monitor. This substantial technical reach compared with 325 million households in 2016 means that SES is now delivering video content to more than 1 billion global viewers.

SES’s increased technical reach reflects the expansion of the survey with the addition of new countries (Ethiopia, Tanzania, Uganda and Turkey) and the wider reach of Yahlive, namely in the Maghreb countries, together accounting for 17 million more SES TV homes. On a like-for-like basis, the technical reach grew by 9 million SES TV homes, mainly in Nigeria, Ghana and the Middle East.

Out of its 351 million TV homes, SES directly reaches 145 million, and indirectly serves another 147 million cable homes, 40 million IPTV homes, and 18 million terrestrial homes.

The Satellite Monitor shows that Europe continues to be a strong and resilient market where satellite broadcasting is a highly attractive platform for reliable and cost-effective video delivery to large audiences. SES now reaches 167 million TV homes in Europe, up from 156 million in 2016. This growth is mainly driven by the addition of Turkey and the additional reach of Yahlive in the Maghreb countries, which together represent an increase of 10 million TV homes. Technical reach across the core markets in Europe was stable.

The study also shows the key role of SES to deliver HD content: today, SES delivers HD content to 107 million homes, which represents two thirds of all European TV homes enjoying HD. As the leading HD platform, SES carries 2,602 HD channels worldwide, out of 7,709 channels in total. In Europe, SES delivers 2,670 TV channels, including 798 in HD.

In Africa, SES now reaches 30 million homes. In West Africa, SES has seen a strong growth with an increase from 3 million homes to 11 million in Nigeria, and from 2 million to 4 million in Ghana. Ethiopia, Uganda and Tanzania – which are being included in the Satellite Monitor for the first year – account for 7 million homes. Through Yahlive, a joint venture between SES and Yahsat, SES serves 13 million homes in the Middle East and South West Asia, up from 11 million TV homes in 2016. For the rest of the world, SES reaches 32 million homes in Asia-Pacific, 75 million homes in North America, and 33 million in Latin America.

“The Satellite Monitor shows that our strategy to invest in growth markets is successful and results in a significantly larger geographical reach,” said Ferdinand Kayser, CEO of SES Video. “We continue to leverage our growing, unique technical reach worldwide to help our customers build their businesses and expand their audiences. In Africa, our infrastructure will continue to play a key role in the digital switch-over, while in developed countries, namely Europe, our satellites remain the leading platform to deliver HD and drive Ultra HD to millions of households. We are also strongly supporting the development and roll-out of HD and Ultra HD in the Americas and Asia Pacific.”

Follow us on:

Social Media

Blog

Media Library

White Papers

About SES

SES is a world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 16 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in two key business units: SES Video and SES Networks. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions. SES’s portfolio includes ASTRA, O3b and MX1, a leading media service provider that offers a full suite of innovative digital video and media services. SES is listed on the Euronext Paris and Luxembourg Stock Exchange (ticker: SESG). Further information available at: www.ses.com





View source version on businesswire.com: https://www.businesswire.com/news/home/20180403006038/en/

Contacts

SES
Markus Payer
Corporate Communications & PR
Tel. +352 710 725 500
Markus.Payer@ses.com


http://www.aetoswire.com/news/ses-reaches-351-million-tv-homes-worldwide/en

New xQR41V Needle Valve from Nordson EFD is Next Generation Dispensing Technology

 60% smaller, modular needle valve with Quick Release clasp is easy to clean and maintain in under 2 minutes – reducing downtime while boosting productivity



EAST PROVIDENCE, R.I. -Tuesday, April 3rd 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Nordson EFD, a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, introduces the xQR41V Series needle valve. The valve features a 60% smaller form factor than standard valves, an exchangeable, modular design for greater customization and process control, and a patent-pending Quick Release (QR) clasp to replace wetted parts in seconds. The new valve expands manufacturing opportunities for multiple applications and industries, especially those related to electronics, automotive, medical, and general industry.

With a smaller profile of 64 mm length x 23.7 mm diameter (2.50” x 0.93”), operators can mount several xQR41V needle valves close together for greater output per batch. Ideal for automated assembly processes, the smaller form factor makes it easier to dispense in tight spaces and at more complex angles. It also results in a smaller wetted path, resulting in less retained fluid volume, which minimizes fluid waste.

The design of the xQR41V makes it suitable for use with all Nordson EFD dispensing tips, including general purpose and SmoothFlow™ tapered tips. Its modularity allows it to be configured with a BackPack™ valve actuator or low-profile mounting block and 90° or straight fluid inlet fittings so operators can adjust the valve to meet different application requirements. The BackPack actuator allows high-speed cycle rates exceeding 60-80Hz. Modular parts are available pre-installed on new valves or can be ordered separately to retrofit onto existing valves.

“A lot of thought and consideration went into the design of the xQR41V needle valve,” said Claude Bergeron, product line manager – valves, Nordson EFD. “It was designed to deliver the exceptional accuracy and repeatability an EFD dispense valve is known for, as well as versatility to use with a wide range of fluid viscosities and application requirements.”

Combined with a 60% smaller size and the QR clasp, which reduces downtime for maintenance to less than two minutes, the xQR41V is the next generation of precision dispensing technology.

For more information, visit Nordson EFD on the web at nordsonefd.com/xQR41V, facebook.com/NordsonEFD, or linkedin.com/company/nordson-efd, email at info@nordsonefd.com, or call +1 401.431.7000 or 800.556.3484.

About Nordson EFD

Nordson EFD designs and manufactures precision fluid dispensing systems for benchtop assembly processes and automated assembly lines. By enabling manufacturers to apply the same amount of adhesive, lubricant or other assembly fluid to every part, every time, EFD dispensing systems are helping companies in a wide variety of industries increase throughput, improve quality, and lower their production costs. Other fluid management capabilities include high-quality syringe barrels and cartridges for packaging one- and two-component materials, along with a wide variety of fittings, couplers and connectors for controlling fluid flow in medical, biopharmaceutical and industrial environments. The company is also a leading formulator of specialty solder pastes for dispensing and printing applications in the electronics industry.

About Nordson Corporation

Nordson engineers, manufactures, and markets differentiated products and systems used for dispensing and processing adhesives, coatings, polymers, sealants and biomaterials; and for managing fluids, testing and inspecting for quality, treating surfaces and curing. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, energy, transportation, building and construction, and general product assembly and finishing. Founded in 1954 and headquartered in Westlake, Ohio, the company has operations and support offices in more than 30 countries. Visit Nordson on the web at nordson.com, twitter.com/Nordson_Corp or facebook.com/nordson.





View this news release and multimedia online at:
http://www.businesswire.com/news/home/20180403005094/en

Contacts

Nordson EFD
Natalie Tomasso, +1-401-431-7173 (USA)
Marketing Communications Specialist
Natalie.Tomasso@nordsonefd.com
or
Nordson EFD
Global
Natalie Tomasso, +1-401-431-7173
natalie.tomasso@nordsonefd.com
or
Europe
+44 (0) 1582 666334
europe@nordsonefd.com
or
China
+86 (21) 3866 9006
china@nordsonefd.com
or
Japan
+81 (03) 5762 2760
japan@nordsonefd.com
or
SEAsia
+65 6796 9522
sin-mal@nordsonefd.com
or
India
+91 80 4021 3600
india@nordsonefd.com

Permalink : http://aetoswire.com/news/new-xqr41v-needle-valve-from-nordson-efd-is-next-generation-dispensing-technology/en

Gemalto Provides Customers Enhanced Data Security for Cloud, Hybrid and on-Premises Data Storage Deployments With NetApp

Gemalto SafeNet KeySecure integration with NetApp provides centralized key management for thousands of volumes across multiple clusters

AMSTERDAM -Tuesday, April 3rd 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, today announced that SafeNet KeySecure has been validated for use with the latest release of NetApp® Volume Encryption (NVE) data management solution. As a result, NetApp customers do not need to encrypt the entire disk drive; they can choose to encrypt granularly at the volume level without the need and additional cost of purchasing self encrypting drives (SEDs), while retaining key benefits such as centralized key management and access control, better compliance, and high availability.

Data privacy and data security continues to be a key focus for organizations, especially in light of industry compliance standards such as US health standard (HIPAA) or payment card standard (PCI-DSS) and the EU’s General Data Protection Regulation (GDPR). SafeNet KeySecure centralizes cryptographic processing, security policy and key management, while offering NetApp customers the ability to store and manage encryption keys centrally and separately, away from the encrypted data ensuring security and facilitating compliance.

“Data has become one of the most valuable assets for organizations, but as with anything with value, criminals are determined to get their hands on it,” said Todd Moore, Gemalto Senior Vice President for Encryption Products. “With legislation forcing companies to reveal breaches such as the GDPR, which is due to come into effect in May, there will be nowhere for organizations to hide. This increase in attention means that they must find a way to control who has access to their data and ensure they’re putting in the necessary tools to protect it.”

The Gemalto SafeNet KeySecure solution builds on the NetApp Data Fabric software approach, which simplifies and integrates data management across the cloud and on premises to accelerate digital transformation. On top of having more granular data encryption and keeping keys separate, customers will have the freedom to choose any storage media, have flexible deployment options, audit trails, separation of duties and ecosystem support.

“The NetApp Alliance Partner Program enables us to join forces with the best and brightest in the industry, to address the storage and data infrastructure needs of today’s complex enterprise environments,” said Deepak Visweswaraiah, Senior Vice President, Manageability Products and Solutions Group, at NetApp. “As a result of working with the world leader in digital security, we can now offer our customers peace-of-mind that their data is safe and compliant.”

For more information on Gemalto SafeNet KeySecure:

    Read this blog: Benefits of External Key Management for Storage
    Download the SafeNet KeySecure and SafeNet Virtual KeySecure product briefs

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2017 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.

From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.

Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.

Our 15,000 employees operate out of 114 offices, 40 personalization and data centers, and 35 research and software development centers located in 47 countries.

For more information visit www.gemalto.com, or follow @gemalto on Twitter.

NETAPP, the NETAPP logo, and the marks listed at http://www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.



View source version on businesswire.com: https://www.businesswire.com/news/home/20180402005033/en/

Contacts

Gemalto media contacts:
Tauri Cox
North America
+1 512 257 3916
tauri.cox@gemalto.com
or
Sophie Dombres
Europe Middle East & Africa
+33 4 42 55 36 57 38
sophie.dombres@gemalto.com
or
Jaslin Huang
Asia Pacific
+65 6317 3005
jaslin.huang@gemalto.com
or
Enriqueta Sedano
Latin America
+52 5521221422
enriqueta.sedano@gemalto.com

Permalink : http://aetoswire.com/news/gemalto-provides-customers-enhanced-data-security-for-cloud-hybrid-and-on-premises-data-storage-deployments-with-netapp/en

ResMed Hires Bobby Ghoshal as First Chief Technology Officer

SAN DIEGO-Tuesday, April 3rd 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first chief technology officer (CTO), Bobby Ghoshal, effective today.

As CTO, Ghoshal will lead ResMed’s global healthcare informatics and data analytics team to drive its world-leading cloud-based digital health platforms as well as investments in emerging health technologies like artificial intelligence and machine learning.

Ghoshal has more than 25 years’ experience in information technology, semiconductor innovation, digital strategy, information security, advanced analytics, operations and customer care. Since 2016, Ghoshal has been chief operating officer at Brightree, a ResMed-owned provider of cloud-based software-as-a-service for out-of-hospital care. From 2012 to 2016, he was vice president of information technology at ResMed. Previously, Ghoshal worked in a number of management and technical roles in the semiconductor and financial industries.

“Bobby has played several key roles in ResMed’s emergence as a world-leading connected health company this past decade, and we’re excited to appoint him as our new CTO,” said ResMed CEO Mick Farrell. “I have worked with Bobby for many years and he has incredible energy, integrity, intelligence and an always-learning attitude that will guide ResMed’s emerging competence in artificial intelligence, machine learning, deep neural networks and other data analytics technologies to change the lives of millions more patients.”

“I’m excited to lead ResMed’s extraordinary healthcare informatics team to help drive the value of connected health, leveraging the power of technology and data for the hundreds of millions of people who suffer from sleep apnea, COPD, and related chronic diseases worldwide,” said Ghoshal.

ResMed’s Healthcare Informatics team had been led by Raj Sodhi, current president of ResMed’s software-as-a-service businesses, pioneering out-of-hospital software growth globally.

“I’m excited for Bobby’s return to the ResMed team,” Sodhi said. “With Bobby as CTO, I can be fully focused on expanding the capabilities of ResMed’s SaaS solutions for out-of-hospital care, while Bobby leads the next level of tech innovation, investments and partnerships that will take our digital health capabilities to new frontiers, for the ultimate benefit of patients, physicians, providers and payers.”

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20180402005222/en/

Contacts

ResMed
For media:
Jayme Rubenstein, +1 858-836-6798
news@resmed.com
or
For investors:
David Pendarvis, +1 858-836-5983
investorrelations@resmed.com

Permalink : http://aetoswire.com/news/resmed-hires-bobby-ghoshal-as-first-chief-technology-officer/en

PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme

DAEJEON, South Korea-Monday, April 2nd 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announced today that U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading clinical compound TTAC-0001 for “treatment of Glioblastoma Multiforme.”

“We are very pleased with this Orphan Drug Designation from FDA for TTAC-0001 for GBM treatment since we have been preparing for clinical studies of TTAC-0001 plus KEYTRUDA® (pembrolizumab) combo therapy for recurrent GBM in addition to TTAC-0001 mono therapy for recurrent GBM progressed after bevacizumab treatment. It will accelerate the progress of TTAC-0001 to provide clinical benefit in the treatment of GBM,” said Dr. Jin-San Yoo, president and chief executive officer of PharmAbcine, Inc.

The FDA Office of Orphan Products Development grants Orphan Drug Designation to investigational drugs and biologics that are intended for the treatment of rare diseases that affect fewer than 200,000 people in the U.S. Orphan drug status is intended to facilitate drug development for rare diseases and may provide several benefits to drug developers, including seven years of market exclusivity upon regulatory product approval, exemptions from certain FDA application fees, and tax credits for qualified clinical trials costs.

About TTAC-0001 (=Tanibirumab)

PharmAbcine’s lead candidate TTAC-0001, an investigational therapy, is a highly selective and potent anti-VEGFR2 (KDR/flk-1) mAb in clinical development for rGBM indications. VEGFR2 is over-expressed in most malignant tumors, such as gastric, liver, non-small cell lung cancer (NSCLC), ovarian, brain, colorectal, and breast cancers and this signaling pathway is a key regulator for tumor angiogenesis.

Increased understanding of the role of VEGF/VEGFR2 in the tumor vessel formation, immune suppressive modulation of tumor microenvironment (TME) and the function of the antagonist molecule to disorganized tumor vessel normalization, immune supportive modulation, and ultimately tumor vessel disruption, supports the rationale for evaluating TTAC-0001 in GBM, rGBM and Avastin® (bevacizumab) refractory GBM.

About PharmAbcine Inc.

PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-house developed novel platform, DIG-Body, PIG-Body and TIG-Body using innovative discovery technology and excellent human resources for the treatment of human diseases, such as cancer and inflammatory diseases.

PharmAbcine’s fully human antibody libraries and innovative selection system are our priceless proprietary assets. PharmAbcine provides antibody generation services by using antibody library and selection systems. PharmAbcine also provides co-development opportunities with novel antibodies.

Under the collaboration with SAMSUNG MEDICAL CENTER, PharmAbcine has >300 patients derived cancer stem cell libraries and its animal model system for evaluating internal pipeline development.

Selected pipeline:

TTAC-0001(=Tanibirumab): anti-KDR neutralizing fully human IgG with unique cross species cross reactivity has completed its Phase IIa recurrent GBM trial in Australia in August 2017 and its final report will be available early in 2018. Promising molecule to combine with immune checkpoint blockade is open for out-licensing, co-development and combination clinical trials.

PMC-001(=DIG-KT): next generation bispecific antibody neutralizing both VEGF-KDR and Angiopoietin-TIE2 pathways is superior to bevacizumab and Tanibirumab in preliminary studies. It also overcomes the Avastin resistant brain tumor growth. PMC-002, PMC-003, PMC-004 are derivative molecules from PMC-001.

PMC-201: next generation bispecific antibody neutralizing both VEGF-KDR and Notch-DLL4 pathways overcomes anti-cancer drug resistant tumor growth.

PMC-005B: Anti-EGFRviii truly specific fully human IgG with internalization property is perfect for ADC, CAR-T and CAR-NK purpose and is open for codevelopment or out-licensing.

PMC-309a-z: anti-VISTA fully human antibodies collection as either agonistic or antagonistic. Antagonistic antibody performed synergy effects in combination with other immuno-oncology drug.

"3G-System" platform provides high performing production cell lines and we do have both

PMC-901: bevacizumab biosimilar cell line with 3g/L productivity.
PMC-902: aflibercept biosimilar cell line with >3g/L productivity.

Additional information about PharmAbcine is available through its website, https://www.pharmabcine.com

About GBM, recurrent GBM and Avastin refractory recurrent GBM

Glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults, with a median survival of less than 15 months from diagnosis and recurs frequently within a year following the initial treatment. Chemotherapy, radiation and surgery are the primary initial treatments; chemotherapy and surgery may be possible for recurrent disease, with limitations in using radiation dependent on the site of recurrence. Avastin is approved as an active treatment option (single agent) for patients with rGBM who have failed previous TMZ and radiation therapy. During Avastin treatment, some of patients become Avastin refractory recurrent GBM.



Contacts

Media Contacts
For PharmAbcine:
Dr. Sung Woo Kim, 82-42-863-2017
sungwoo.kim@pharmabcine.com



Permalink : http://aetoswire.com/news/pharmabcine-announces-fda-orphan-drug-designation-granted-to-ttac-0001-for-glioblastoma-multiforme/en

Toshiba Corporation Welcomes Nobuaki Kurumatani as Chairman and CEO

TOKYO-Monday, April 2nd 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Nobuaki Kurumatani today took office as the first Chairman and CEO of Toshiba Corporation (TOKYO:6502) to be appointed from outside the company in over 50 years.

Commenting on his appointment as Representative Executive Officer and Chairman and CEO, Mr. Kurumatani said, “I am honored to be appointed CEO, and very much aware of the responsibilities I take on. Toshiba is not just any company. Its corporate DNA has realized countless Japan- and world-first technologies and products, made Toshiba a source of pride in Japan for nearly 145 years, and also made us a global leader.

“I believe that helping Toshiba back on its feet is my true calling. I am here at Toshiba to support change and transformation, and I see my role as to build on the company’s resilience and to lead its recovery. To secure growth, we must radically improve our earning power and reinforce our finances. We must move out of our comfort zone and promote fundamental reforms.”

Mr. Kurumatani most recently served as President of CVC Asia Pacific Japan (CVC). Before joining CVC in May 2017, he was Deputy President and a Director of Sumitomo Mitsui Financial Group, one of the largest financial institutions in Japan, where his career was devoted to corporate planning, public relations and internal auditing. He is a graduate of the University of Tokyo, where he studied Economics.

Satoshi Tsunakawa has taken on a new role in Toshiba as Representative Executive Officer and President, and Chief Operations Officer (COO). From today on, Mr. Kurumatani and Mr. Tsunakawa will together execute the management of Toshiba Group.

Contacts

Toshiba Corporation
Midori Hara, +81-3-3457-2100
Public Relations & Investor Relations Div.
Fax: +81-3-5444-9202
media.relations@toshiba.co.jp

Permalink : http://aetoswire.com/news/toshiba-corporation-welcomes-nobuaki-kurumatani-as-chairman-and-ceo/en

Huawei Unveils the HUAWEI P20 and HUAWEI P20 Pro, Breakthroughs in Technology and Art to Redefine Intelligent Photography

PARIS-Thursday, March 29th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Today Huawei Consumer Business Group unveiled the HUAWEI P20 Series. The HUAWEI P20 Pro features the world’s first Leica triple camera and both devices include unprecedented AI advances, combining technology and art to bring to life a groundbreaking smartphone experience.

 “We look for inspiration from artists to continuously evolve our approach to design and innovation,” said Richard Yu, Chief Executive Officer, Huawei Consumer Business Group. “With a breakthrough triple camera on the HUAWEI P20 Pro, an advanced dual camera on the HUAWEI P20 and powerful artificial intelligence on both, today’s most vibrant consumers can capture and share the brilliance of the world around them.”

Key features of the HUAWEI P20 Series include:

An advanced camera to capture more light, featuring a Leica triple camera and 5x Hybrid Zoom on the HUAWEI P20 Pro, and a Leica dual camera on the HUAWEI P20, both achieving DxOMark’s highest overall scores1;
Innovative photography features, including AI-powered professional photography features and HUAWEI AIS (AI Image Stabilization);
A timeless design with barely-there bezels and all-new gradient colors;
Ultimate performance, featuring the NPU on Kirin 970 and EMUI 8.1 based on Android™ 8.1.
A Combination of Art and Technology

The HUAWEI P20 Series comes in Black, Midnight Blue and two all-new gradient colors, Twilight and Pink Gold, achieved by applying several layers of NCVM* optical coatings underneath the glass back, so light hitting the surface refracts and creates a vivid, yet gradual change of hue.

The 5.8-inch screen HUAWEI P20 and 6.1-inch screen HUAWEI P20 Pro feature HUAWEI FullView Display, ultra-thin bezels and impressive screen-to-body ratios for better viewing experiences.

Inspired by Light and Technology

The HUAWEI P20 Pro features a Leica triple camera with the highest total pixel count on a smartphone – the camera configuration is comprised of a 40MP RGB sensor, a 20MP monochrome sensor and an 8MP sensor with telephoto lens. It also features an exclusive Leica color temperature sensor for better color reproduction. With f/1.8, f/1.6 and f/2.4 wide aperture to capture crisp, clear details, the HUAWEI P20 Pro also includes a brand new Leica 3x telephoto (VARIO-SUMMILUX-H 1:1.6-2.4/27-80ASPH) lens for long-range photography of up to 5x Hybrid Zoom. The HUAWEI P20 Pro’s highly sensitive image sensor captures low light photos with up to ISO 102400.

The HUAWEI P20 builds on its predecessor’s foundation with a Leica dual camera featuring a 12MP sensor with a pixel size as high as 1.55 μm, and a 20MP monochrome sensor, enhancing the HUAWEI P20’s ability to capture photos in low-light settings.

The HUAWEI P20 Series devices support six-axis stabilization and 960fps super slow motion. With Ultra Snapshot mode, the devices can capture an image in as little as 0.3 seconds by just double clicking the down volume button, even from an off screen.

Master AI Photography Experience

With the Kirin 970 processor, the HUAWEI P20 Series automatically identifies more than 500 scenarios in 19 categories, selecting camera settings to deliver professional-looking images. HUAWEI AIS steadies handheld night shots for incredible long exposure images without a tripod. Brand new to Huawei’s advanced camera system is 4D predictive focus, predicting moving objects and focusing on them with extreme efficiency to capture minute detail. The HUAWEI P20 Series also features AI-Assisted Composition, providing intelligent suggestions to frame group shots and landscapes.

The HUAWEI P20 and HUAWEI P20 Pro feature a 24MP selfie camera** with AI beautification and 3D portrait lighting. The HUAWEI P20 Series also includes on-device Prisma processing, which supports real-time filter recommendations based on scene and object recognition.

In partnership with Google, the HUAWEI P20 Series supports Google ARCore, delivering advanced AR capabilities.

Collaboration with Porsche Design

Huawei also unveiled the PORSCHE DESIGN HUAWEI Mate RS. Continuing its collaboration with the exclusive luxury brand, the PORSCHE DESIGN HUAWEI Mate RS features Porsche Design’s signature functional design language and Huawei’s cutting-edge technology and craftsmanship, setting a new standard in premium smartphones.

Pricing and Availability

The HUAWEI P20 Series and PORSCHE DESIGN HUAWEI Mate RS are immediately available globally.

Model





Version





EUR (includes tax)

HUAWEI P20





4GB + 128GB





€649

HUAWEI P20 Pro





6GB + 128GB





€899

PORSCHE DESIGN HUAWEI Mate RS





6GB + 256GB





€1,695

PORSCHE DESIGN HUAWEI Mate RS





6GB + 512GB





€2,095

*Non-conductive Vacuum Metalizing
**24.8MP sensor

For more information please visit: https://consumer.huawei.com/en/

1 Highest overall DxOMark scores in the mobile camera category – HUAWEI P20 Pro: 109; HUAWEI P20: 102.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180327005811/en/

Contacts
Racepoint Global for Huawei Consumer BG
Lisa Kennedy, 1-415-694-6700
Huawei@racepointglobal.com

Permalink : http://aetoswire.com/news/huawei-unveils-the-huawei-p20-and-huawei-p20-pro-breakthroughs-in-technology-and-art-to-redefine-intelligent-photography/en